您的位置: 首页 > 农业专利 > 详情页

NOUVELLE IMMUNOTHÉRAPIE CONTRE PLUSIEURS TUMEURS DU SANG, TELS QUE LA LEUCÉMIE MYÉLOÏDE AIGUË (AML)
专利权人:
immatics Biotechnologies GmbH
发明人:
申请号:
EP19185183.1
公开号:
EP3604327A1
申请日:
2015.05.08
申请国别(地区):
EP
年份:
2020
代理人:
摘要:
The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to several novel peptide sequences and their variants derived from HLA class I and HLA class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充